Skip to main content

Taisho Subscribes to Inpharmatica s Biopendium Database

NEW YORK, March 29 (GenomeWeb News) - Inpharmatica has licensed its Biopendium Online genome annotation database to Taisho Pharmaceuticals of Japan, the company said today.

 

Taisho is the third Japanese subscriber to Biopendium, and the first to choose the online version, which was launched last year, according to Inpharmatica, which is based in London.

 

Biopendium, part of Inpharmatica's PharmaCarta chemogenomics platform, contains annotations for 1.4 million sequences from 150 genomes.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.